Ribziff D Tablet is a dual-action combination of Domperidone (10mg) and Rabeprazole (20mg) designed to treat gastrointestinal issues such as acid reflux, indigestion, and nausea. The synergistic effect of these two active ingredients provides comprehensive relief from a variety of digestive disorders by targeting both motility and acid production in the stomach.
Domperidone, a dopamine antagonist, helps to enhance gastric motility by increasing the movement of food through the stomach and intestines. This prevents delayed gastric emptying, reducing the sensation of bloating, fullness, and nausea that often accompany indigestion and gastroesophageal reflux disease (GERD). Domperidone also reduces vomiting, making it effective in treating nausea caused by various conditions.
Rabeprazole, a proton pump inhibitor (PPI), works by blocking the proton pump in the stomach lining that produces gastric acid. By reducing the amount of acid in the stomach, Rabeprazole helps to heal ulcers, manage GERD, and alleviate heartburn. It also provides relief from gastric irritation caused by excessive acid, supporting the overall healing of the stomach lining.
Together, Ribziff D Tablet offers a combined treatment that effectively addresses both acid-related issues and gastric motility disorders. It is commonly used to treat conditions like GERD, peptic ulcers, and functional dyspepsia, where acid overproduction and poor gastric motility are key contributing factors. Additionally, it can help manage nausea and vomiting due to various causes.